Daré Bioscience Announces Positive Efficacy Results from the DARE-HRT1 Phase 1 / 2 Study
Statistically Significant Results for Improvement in both the Vasomotor and the Vaginal Symptoms of Menopause…
Read More...
Read More...
Browsing Tag
Daré
Daré Bioscience Announces IDE Approval for a Single Arm, Open-Label Pivotal Contraceptive Efficacy…
SAN DIEGO, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health…
Read More...
Read More...
Chhavi Mittal talks about tackling painful side effects of radiotherapy after surgery: ‘Jab…
Actor Chhavi Mittal has spoken about the side effects of radiation, she is going through, post her breast cancer…
Read More...
Read More...
Daré Bioscience to Participate in Upcoming Conference
SAN DIEGO, April 14, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health…
Read More...
Read More...
Daré Announces FDA Approval of XACIATO™ (clindamycin phosphate) Vaginal Gel as a Treatment for…
Prescribing information supports positioning of XACIATO as a first line option for the treatment of bacterial…
Read More...
Read More...